Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11784734 | 1.00 | OPRM1 (0.35) | OPRM1SPHK1LMNAADH1BADH1C | |
| SCHEMBL6906996 | 0.89 | OPRM1 (0.33) | OPRM1SPHK1LMNAADH1BADH1C | |
| SCHEMBL16945865 | 0.87 | OPRM1 (0.32) | OPRM1 | |
| SCHEMBL28891719 | 0.81 | OPRM1 (0.31) | OPRM1SPHK1 | |
| SCHEMBL28419912 | 0.81 | OPRM1 (0.31) | OPRM1SPHK1 | |
| SCHEMBL28425725 | 0.81 | OPRM1 (0.31) | OPRM1SPHK1 | |
| SCHEMBL5671810 | 0.80 | ZDHHC7 (0.36) | OPRM1SPHK1LMNADNM1SMPD1 | |
| SCHEMBL5669699 | 0.80 | ZDHHC7 (0.36) | OPRM1SPHK1LMNADNM1SMPD1 | |
| SCHEMBL28418369 | 0.79 | OPRM1 (0.31) | OPRM1 | |
| SCHEMBL5671671 | 0.78 | OPRM1 (0.37) | OPRM1SPHK1LMNADNM1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858821-B2 | Method of silica pretreatment | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2024-01-02 | — | — | US | claimed |
| EP-4023724-A2 | METHOD OF MAKING HYDROPHOBATED SILICA AND USE OF SUCH A SILICA | The Goodyear Tire & Rubber Company (US) | 2022-07-06 | — | — | EP | claimed |
| US-20220204351-A1 | METHOD OF SILICA PRETREATMENT | GOODYEAR TIRE & RUBBER COMPANY, THE | 2022-06-30 | — | — | US | claimed |
| US-7794782-B2 | Phosphonate and sulfido silane anti-corrosion additive for electrical cable restoration fluid | DOW CORNING CORPORATION (US) | 2010-09-14 | — | — | US | claimed |
| US-20070235700-A1 | Phosphonate and Sulfido Silane Anti-Corrosion Additve for Electrical Cable Restoration Fluid | DOW CORNING CORPORATION | 2007-10-11 | — | — | US | claimed |
| EP-1769512-A1 | ANTI-CORROSION ADDITIVE FOR ELECTRICAL CABLE RESTORATION FLUIDS | Dow Corning Corporation (US) | 2007-04-04 | — | — | EP | claimed |
| WO-2005124792-A1 | ANTI-CORROSION ADDITIVE FOR ELECTRICAL CABLE RESTORATION FLUIDS | DOW CORNING CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| US-20040034150-A1 | Rubber compositions and method for increasing the mooney scorch value | UNIROYAL CHEMICAL COMPANY, INC. | 2004-02-19 | — | — | US | claimed |
| US-6620875-B2 | Silica filler, coupling agent, cure-enhancing polyoxyalkylene oxide and high molecular weight thiuram disulfide; carbon black; ozone and oxidation resistance; tire treads | UNIROYAL CHEMICAL COMPANY, INC. | 2003-09-16 | — | — | US | claimed |
| US-20030119995-A1 | Silica filler, coupling agent, cure-enhancing polyoxyalkylene oxide and high molecular weight thiuram disulfide; carbon black; ozone and oxidation resistance; tire treads | ADDIVANT USA, LLC | 2003-06-26 | — | — | US | claimed |
| US-20030119960-A1 | Rubber compositions and method for decreasing the tangent delta value | UNIROYAL CHEMICAL COMPANY, INC. | 2003-06-26 | — | — | US | claimed |
| US-6465670-B2 | SURFACE TREATMENT USING ORGANOSILICON COMPOUND, SOLVENT AND PHASE TRANSFER CATALYST | THE GOODYEAR TIRE & RUBBER COMPANY | 2002-10-15 | — | — | US | claimed |
| US-6390163-B1 | BUTADIENE OR ISOPRENE-STYRENE COPOLYMER | THE GOODYEAR TIRE & RUBBER COMPANY | 2002-05-21 | — | — | US | claimed |
| US-20020022085-A1 | Preparation of surface modified silica | GOODYEAR TIRE & RUBBER COMPANY, THE | 2002-02-21 | — | — | US | claimed |
| US-6326424-B1 | BUTADIENE-ISOPRENE COPOLYMER | THE GOODYEAR TIRE & RUBBER COMPANY | 2001-12-04 | — | — | US | claimed |
| US-6053226-A | BLENDING A DIENE BASED ELASTOMER, A REINFROCEMENT FILLER COMPRISED OF PRECIPITATED SILICA AND CARBON BLACK, A PREFORMED COMPOSITE OF MICROCRYSTALLINE WAX, SILICA COUPLING AGENT, ANTIDEGRADANT, VULCANIZATION PROMOTER AND CARBON BLACK | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2000-04-25 | — | — | US | claimed |
| EP-0764688-B1 | High performance blend for tire treads | GOODYEAR TIRE & RUBBER (US) | 2000-02-23 | — | — | EP | claimed |
| EP-0941872-A2 | Rubber composition reinforced with silica and tire with tread thereof | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1999-09-15 | — | — | EP | claimed |
| EP-0764688-A1 | High performance blend for tire treads | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1997-03-26 | — | — | EP | claimed |
| US-5534592-A | POLYBUTADIENE RUBBER BLEND | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1996-07-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020022085-A1 | Preparation of surface modified silica | OSTC, SAMM50, SSRP1 | OPRM1 596/4885SPHK1 295/4885LMNA 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.